The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...
BILTHOVEN, Netherlands, Jan. 19, 2021 /PRNewswire/ -- Intravacc, a world leader in translational research and development of vaccines, today announced that a candidate polyvalent inactivated ...
LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...
The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company dedicated to the development of novel small-molecule therapeutics for the ...
Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support ...
WuXi STA, a subsidiary of WuXi AppTec, reports that a new parenteral formulation manufacturing line has started operation at the drug product site in Wuxi city, China. It is the second line opened ...
DFE Pharma launches continuous manufacturing platform to accelerate and enable formulation development: Goch, Germany Wednesday, February 18, 2026, 12:00 Hrs [IST] DFE Pharma, a g ...
DCGI instructs state FDAs to ensure digitization of manufacturing sites & formulation data on Sugam portal: Laxmi Yadav, Mumbai Monday, February 4, 2019, 08:00 Hrs [IST] The Drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results